Skip to main content
Article thumbnail
Location of Repository

Integrin/Fak/Src-mediated regulation of cell survival and anoikis in human intestinal epithelial crypt cells: selective engagement and roles of PI3-K isoform complexes

By Marco Beauséjour, Dominique Noël, Sonya Thibodeau, Véronique Bouchard, Charlène Harnois, Jean-François Beaulieu, Marie-Josée Demers and Pierre H. Vachon


In human intestinal epithelial crypt (HIEC) cells, the PI3-K/Akt-1 pathway is crucial for the promotion of cell survival and suppression of anoikis. Class I PI3-K consists of a complex formed by a catalytic (C) and regulatory (R) subunit. Three R (p85α, β, and p55γ) and four C (p110α, β, γ and δ) isoforms are known. Herein, we analyzed the expression of PI3-K isoforms in HIEC cells and determined their roles in cell survival, as well as in the β1 integrin/Fak/Src-mediated suppression of anoikis. We report that: (1) the predominant PI3-K complexes expressed by HIEC cells are p110α/p85β and p110α/p55γ; (2) the inhibition and/or siRNA-mediated expression silencing of p110α, but not that of p110β, γ or δ, results in Akt-1 down-activation and consequent apoptosis; (3) the expression silencing of p85β or p55γ, but not that of p85α, likewise induces Akt-1 down-activation and apoptosis; however, the impact of a loss of p55γ on both Akt-1 activation and cell survival is significantly greater than that from the loss of p85β; and (4) both the p110α/p85β and p110α/p55γ complexes are engaged by β1 integrin/Fak/Src signaling; however, the engagement of p110α/p85β is primarily Src-dependent, whereas that of p110α/p55γ is primarily Fak-dependent (but Src-independent). Hence, HIEC cells selectively express PI3-K isoform complexes, translating into distinct roles in Akt-1 activation and cell survival, as well as in a selective engagement by Fak and/or Src within the context of β1 integrin/Fak/Src-mediated suppression of anoikis

Topics: Original Paper
Publisher: Springer US
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2000). A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alphap110beta) in de novo DNA synthesis of human colon carcinoma cells.
    2. (2011). Akt signalling in health and disease.
    3. (2011). Apoptosis: why and how does it occur in biology? Cell Biochem Funct 29:468–480
    4. Bilancio A et al (2005) Signalling by PI3-K isoforms: insights from gene-targeted mice.
    5. (2010). Biology of colorectal cancer.
    6. (2011). Borgstro ¨m A, Arcaro A
    7. (2006). Cell survival: differences and differentiation. Med Sci
    8. (2008). Class I PI3K in oncogenic cellular transformation.
    9. (2004). Death by design: apoptosis, necrosis and autophagy.
    10. Demers M-J et al (2008) b1 integrin/Fak/ Src signaling in intestinal epithelial crypt cell survival: integration of complex regulatory mechanisms.
    11. (2007). Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
    12. (2001). Five isoforms of the phosphatidylinositol 3-kinase regulatory subunit exhibit different associations with receptor tyrosine kinases and their tyrosine phosphorylations.
    13. (2009). Focal adhesion kinase and cancer.
    14. (2009). Functional development of human fetal gastrointestinal tract.
    15. (2005). Gastrointestinal tract. In: Unsicker K, Kriegelstein K (eds) Cell signaling and growth factors in development II.
    16. (2002). Get a ligand, get a life: integrins, signaling and cell survival.
    17. Grenier A et al (2002) Differentiation state-selective roles of p38 isoforms in human intestinal epithelial cell anoikis.
    18. (2009). How adhesion signals reach mitochondrial conclusion-ECM regulation of apoptosis.
    19. (2000). Human cell models to study small intestinal functions. Recapitulation of the crypt-villus axis.
    20. (2004). Human intestinal epithelial cell survival and anoikis. Differentiation state-distinct regulation and roles of protein kinase B/Akt isoforms.
    21. (2001). Human intestinal epithelial cell survival: differentiation state-specific control mechanisms.
    22. (2004). Human intestinal epithelial crypt cell survival and death: complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1, MEK/Erk, and p38 signaling pathways.
    23. (2011). Integrin signaling, cell survival, and anoikis: distinctions, differences, and differentiation.
    24. (2009). Integrin signalling at a glance.
    25. (2010). Integrin-linked kinase regulates migration and proliferation of human intestinal cells under a fibronectin-dependent mechanism.
    26. (2006). Integrin-regulated FAK-Src signaling in normal and cancer cells.
    27. (2009). Integrins and cell-fate determination.
    28. (2008). Is Src the key to understanding metastasis and developing new treatments for colon cancer? Nat Clin Pract Gastroenterol Hepatol 5:306–307
    29. (2012). Isolation, characterization, and culture of normal human intestinal crypt and villus cells.
    30. Larrive ´e J-F, Groulx J-F et al (2010) Integrin alpha8beta1 confers anoikis susceptibility to human intestinal epithelial crypt cells.
    31. Leal Mdel P et al (2010) Integrins and signal transduction.
    32. (2010). Live free or die: tales of homeless (cells) in cancer.
    33. (2005). Mechanisms of disease: PI3K/AKT signaling
    34. (1999). Methods for studying anoikis. In: Howlett AR (ed) Methods in molecular biology, vol 129: integrin protocols.
    35. (2002). Molecular mechanisms of ‘‘detachmentinduced apoptosis-anoikis’’.
    36. Noe ¨l D et al (2009) Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1.
    37. (2006). Oncogenic PI3-K and its role in cancer.
    38. (2011). PI-3-Kinase inhibitors in colorectal cancer.
    39. (2004). PI3-K/Akt pathway: its functions and alterations in human cancer.
    40. (2008). PI3-K/Akt: getting it right matters.
    41. (2009). PIKKing on PKB: regulation of PKB activity by phosphorylation.
    42. (2006). Regulation of apoptosis during homeostasis and disease in the intestinal epithelium.
    43. (2004). Regulation of Bcl-2 proteins during anoikis and amorphosis.
    44. (2009). Should individual PI3 kinase isoforms be targeted in cancer?
    45. (2011). Strasser A
    46. Suire S et al (2010) PI3K signaling in neutrophils.
    47. (2006). Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma. Ann Surg 243:833–844 Apoptosis
    48. (2011). Targeting PI3K signaling as a therapeutic approach for colorectal cancer.
    49. (2009). Targeting PI3K signalling in cancer: opportunities, challenges and limitations.
    50. (2010). The emerging mechanisms of isoform-specific PI3K signalling.
    51. (2008). The life of a cell: apoptosis regulation by the PI3-K/PKB pathway.
    52. (2011). The molecular machinery regulating apoptosis signal transduction and its implication in human physiology and pathophysiologies.
    53. (2007). The role of integrins in colorectal cancer.
    54. (2005). Tsichlis PN
    55. (1996). Use of the dissociating enzyme thermolysin to generate viable human normal intestinal epithelial cell cultures.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.